within Pharmacolibrary.Drugs.ATC.R;

model R05DB24
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 15 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,
    adminCount     = 1,
    Vd             = 0.15,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.001,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Tipepidine is a centrally acting antitussive (cough suppressant) belonging to the thiambutene class. It has been used mainly in Japan and some other Asian countries for the treatment of cough and is not widely approved or used in many Western countries.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models or quantitative pharmacokinetic parameters for tipepidine in humans were found in available peer-reviewed literature.</p><h4>References</h4><ol><li><p>Hayashi, S, et al., &amp; Nakajima, M (2023). Estimation of contribution of CYP2D6 to tipepidine metabolism in humans and prolongation of the half-life of tipepidine by combination use with a CYP2D6 inhibitor in chimeric mice with humanised liver. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 53(4) 241–247. DOI:<a href=&quot;https://doi.org/10.1080/00498254.2023.2224863&quot;>10.1080/00498254.2023.2224863</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37305902/&quot;>https://pubmed.ncbi.nlm.nih.gov/37305902</a></p></li><li><p>Sugimoto, M, et al., &amp; Kobayashi, M (2001). The preparation of rapidly disintegrating tablets in the mouth. <i>Pharmaceutical development and technology</i> 6(4) 487–493. DOI:<a href=&quot;https://doi.org/10.1081/pdt-120000287&quot;>10.1081/pdt-120000287</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11775950/&quot;>https://pubmed.ncbi.nlm.nih.gov/11775950</a></p></li><li><p>Ogiso, T, et al., &amp; Fujii, Y (1991). Drug interaction between cyproheptadine and tipepidine. Effect of single and repeated administrations. <i>Journal of pharmacobio-dynamics</i> 14(12) 643–653. DOI:<a href=&quot;https://doi.org/10.1248/bpb1978.14.643&quot;>10.1248/bpb1978.14.643</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1812273/&quot;>https://pubmed.ncbi.nlm.nih.gov/1812273</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R05DB24;
